Genetically corrected autologous myogenic cells, associated with nanocapsules as the next generation formula for treatment of Duchenne disease.
2017/25/B/NZ5/01131
Keywords
Descriptors
- NZ5_7: Leczenie chorób człowieka
- NZ3_8: Komórki macierzyste
- ST5_10: Nanomateriały: nanocząstki, nanorurki
Panel
NZ5 – Human and animal noninfectious diseases: etiology, mechanisms, diagnosis and treatment of diseases, poisonings and injuries (without neurological diseases)
Host institution
Instytut Genetyki Człowieka PAN
Voivodeship: wielkopolskie
Principal investigator (from the host institution)
prof. Maciej Krzysztof Kurpisz
Number of co-investigators in the project: 8
Call
OPUS 13 – announced on 2017-03-15
- Amount awarded
- 1 938 185 PLN
- Project start date
- 2018-02-07
- Project end date
- 2023-11-06
- Project duration
- 36 months (the same as in the proposal)
- Project status
- Project completed
Project description
Download the project description in a pdf file
Note — project descriptions were prepared by the authors of the applications themselves and placed in the system in an unchanged form.
Information in the final report
Publications will be made available after the final report has been accepted.